In a historic step, Abu Dhabi and the esteemed University of California have joined up to open the first genetic surgical facilities in the world, with locations in the US and the UAE. The partnership establishes a new international standard for cutting-edge healthcare innovation and represents a significant advancement in genomic medicine.
Precision genetic therapies, such as genome editing, RNA-based therapeutics, and customised gene therapy solutions, will be the main emphasis of the new facilities. The initiative aligns with Abu Dhabi’s long-term vision of becoming a global hub for medical innovation, offering cutting-edge research and treatment options for genetic disorders previously deemed untreatable.
Backed by state-of-the-art facilities, the centres will serve as hubs for clinical trials, translational research, and advanced diagnostics. Leading scientists from both nations will work together to fast-track breakthroughs in rare disease treatments, cancer genomics, and hereditary conditions using tools like CRISPR and mRNA technology.
This strategic partnership further cements Abu Dhabi’s role in reshaping the future of healthcare. It reflects the UAE’s broader commitment to pioneering global solutions through science and technology while fostering international collaborations that benefit humanity at large.
